Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication

O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.

Saved in:
Bibliographic Details
Main Authors KOLONICS ATTILA, TORY KALMAN, BROWNSTEIN MICHAEL, MANDL JÓZSEF, SÜMEGI BALÁZS, NAGY PETER LITERATI, SZILVASSY ZOLTAN, VIGH LASZLO, BALOGH GÁBOR, ROTH JESSE, TAKÁCS KÁLMÁN, BERNATH SANDOR, EGRI JANOS
Format Patent
LanguageEnglish
Published 24.12.2015
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.
Bibliography:Application Number: US201514748150